Transparency
Market Research Reports included a detailed market survey and analysis trends
on “Benign Prostatic Hyperplasia
Therapeutics Market”. This report also includes more info about basic
overview of the industry including definitions, applications and global market
industry structure.
Benign
prostatic hyperplasia (BPH) or benign prostatic hypertrophy, is a urological
disorder that involves proliferation of the cellular components of the
prostrate. BPH is the most common form of neoplasm in men. BPH results in the
formation of large nodes and nodules in the periurethral region of the prostate.
The significantly large nodules compresses the urethral canal that causes to
partial or complete urinary tract obstruction which inhibits the normal flow of
urine. Obstruction in the urinary tract further leads to complications such as
urinary retention, urinary tract infections and urinary hesitancy.
Browse
the full report with request TOC: http://www.transparencymarketresearch.com/bph-therapeutics-market.html
Some
of the medical therapies used for the treatment of BPH are as follows:
- Alpha-Blockers
- 5- Alpha-reductase inhibitors
(5-ARIs)
- Alpha-Adrenergic Blockers
- Phosphodiesterase-5 Enzyme
Inhibitors
- Anticholinergic Agents
- Nonselective alpha-blockers
Some
of the surgical interventions used of the treatment of BPH are as follows:
- Holmium Laser Resection of the
Prostate (HoLRP)
- Open prostatectomy
- Photoselective vaporization of the
prostate (PVP)
- Transurethral holmium laser
ablation of the prostate (HoLAP)
- Transurethral resection of the
prostate (TURP)
- Transurethral vaporization of the
prostate (TUVP)
- Transurethral incision of the
prostate (TUIP)
Geographically,
North America is the leading market due to high prevalence rate of benign
prostatic hyperplasia and lower urinary tract symptoms (LUTS). Various studies
reports that 90% of men in the U.S., aged between 45 and 80 years suffer from
some type of LUTS and approximately 14 million men in the U.S. have symptoms of
BPH. Asia-Pacific is also expected to witness a significant growth due to the
rise in various urological disorders and complications. However, BPH tends to
be more progressive in African-American men owing to the presence of high testosterone
level in their body.
Related
Report: http://www.linkedin.com/groups/ENZYMELINKED-IMMUNOSORBENT-ASSAY-TECHNOLOGIES-MARKET-4394959.S.5856711160375554048
Rise
in geriatric population is expected to be one of the major driver that might
drive the market. Additionally, increased awareness for prostate cancer and
other urological disorders, are also expected to fuel the growth of the global
BPH therapeutics market. However, high adoption rate of minimally invasive
surgeries such as transurethral microwave thermotherapy (TUMT), laparoscopic
prostatectomy and transurethral needle ablation (TUNA) might impede the growth
of the BPH therapeutics market.
Some
of the key players in the benign prostatic hyperplasia (BPH) therapeutics
Market are AEternaZentaris Inc., Astellas Pharma Inc., Eli Lilly and Company,
EndoCeutics, Inc., IntelGenx Technologies Corp., Ipsen S.A., Nymox
Pharmaceutical Corporation, Protox Therapeutics Inc. and Quest PharmaTech Inc.
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This
report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons
for Buying this Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological growth
map over time to understand the industry growth rate
- It provides a seven-year forecast
assessed on the basis of how the market is predicted to grow
- It helps in understanding the key
product segments and their future
· More Reports On Pharmaceutical
Market: - http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
Browse
Market Researche Report:-
0 comments:
Post a Comment